Oncotarget

Research Papers:

Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines

Liangkun You, Jiawei Shou, Danchen Deng, Liming Jiang, Zhao Jing, Junlin Yao, Hongsen Li, Jiansheng Xie, Zhanggui Wang, Qin Pan, Hongming Pan, Wendong Huang and Weidong Han _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:40268-40282. https://doi.org/10.18632/oncotarget.5592

Metrics: PDF 2347 views  |   HTML 2121 views  |   ?  


Abstract

Jin Ho Song1,4, Ki Mun Kang1,4, Hoon-Sik Choi1, Hojin Jeong1,4, In Bong Ha1,4, Jong Deog Lee2, Ho Cheol Kim2, Yi Yeong Jeong2, Yu Ji Cho2, Seung Jun Lee2, Sung Hwan Kim3, In-Seok Jang3, Bae Kwon Jeong1,4

1Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea

2Department of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea

3Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea

4Institute of Health Sciences, Gyeongsang National University, Jinju, Republic of Korea

Correspondence to:

Bae Kwon Jeong, e-mail: blue129j@gnu.ac.kr

Keywords: stereotactic body radiotherapy, lung cancer, calculation algorithm, CyberKnife, Monte Carlo

Received: August 10, 2015     Accepted: October 01, 2015     Published: October 26, 2015

ABSTRACT

Purpose: The purpose of this study was to compare the clinical outcomes between the groups using Ray-Tracing (RAT) and Monte-Carlo (MC) calculation algorithms for stereotactic body radiotherapy (SBRT) of lung tumors.

Materials and Methods: Thirty-five patients received SBRT with CyberKnife for 47 primary or metastatic lung tumors. RAT was used for 22 targets in 12 patients, and MC for 25 targets in 23 patients. Total dose of 48 to 60 Gy was prescribed in 3 to 5 fractions on median 80% isodose line. The response rate, local control rate, and toxicities were compared between RAT and MC groups.

Results: The response rate was lower in the RAT group (77.3%) compared to the MC group (100%) (p = 0.008). The response rates showed an association with the mean dose to the gross tumor volume, which the doses were re-calculated with MC algorithm in both groups. However, the local control rate and toxicities did not differ between the groups.

Conclusions: The clinical outcome and toxicity of lung SBRT between the RAT and MC groups were similar except for the response rate when the same apparent doses were prescribed. The lower response rate in the RAT group, however, did not compromise the local control rates. As such, reducing the prescription dose for MC algorithm may be performed but done with caution.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 5592